These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 20906)
41. [Pharmacology of new beta-adrenergic receptor blocking drugs. II. Bronchopulmonary and cardiovascular effects of VUL 111 and trimepranol (author's transl)]. Drímal J; Seginko J; Gibala P; Strízová K Bratisl Lek Listy; 1978 Oct; 70(4):429-39. PubMed ID: 31233 [No Abstract] [Full Text] [Related]
42. The effects of the new beta-adrenoceptor blocker SL 75212 on the cardiovascular responses to insulin induced hypoglycaemia in man [proceedings]. Kilborn JR; Morselli PL; Saunders J; Sönksen PH Br J Clin Pharmacol; 1979 Oct; 8(4):409P. PubMed ID: 41561 [No Abstract] [Full Text] [Related]
43. The first dose hemodynamic responses to Visacor (ICI 141-292) in essential hypertension. Lund-Johansen P; Omvik P; Haugland H Acta Med Scand Suppl; 1985; 693():121-5. PubMed ID: 2859740 [No Abstract] [Full Text] [Related]
44. [Hypoxemic shock and the myocardium. Effect of cardiovasoactive substances on the course of shock]. Kontokollias JS Fortschr Med; 1986 Oct; 104(38):715-8. PubMed ID: 2877926 [No Abstract] [Full Text] [Related]
45. [Effect of a new beta-receptor blockader (Bunitrolol) on the circulation and metabolism during extreme stress conditions]. Keul J; Huber G; Kindermann W; Burmeister P; Petersen KG Med Welt; 1976 Feb; 27(9):437-43. PubMed ID: 4692 [No Abstract] [Full Text] [Related]
46. [Hemolytic effect of exaprolol and its dependence on the age of rats]. Nicák A; Linková A; Kohút A Bratisl Lek Listy; 1982 Nov; 78(5):554-9. PubMed ID: 6129052 [No Abstract] [Full Text] [Related]
47. Electrocardiographic changes during isoflurane anesthesia suggesting asymptomatic coronary artery disease in three patients. Sprung J; Joseph G; Murray K; O'Hara J Anesthesiology; 1995 Sep; 83(3):628-31. PubMed ID: 7661367 [No Abstract] [Full Text] [Related]
48. [Effects of a beta blockader (SD/1601) associated with a tranquilizing agent (Camazepam) on systemic and coronary hemodynamic modifications due to induced emotional stress in the conscious dog]. Brusoni B; Merlo L; Marchetti G Boll Soc Ital Biol Sper; 1977 Mar; 53(6):445-9. PubMed ID: 20907 [No Abstract] [Full Text] [Related]
49. [Transmural coronary blood flow redistribution in the non-ischemic and ischemic canine myocardium with S 2395, a beta-adrenoceptor blocking agent (author's transl)]. Berdeaux PA; Giudicelli JF Arch Farmacol Toxicol; 1980 Dec; 6(3):209-24. PubMed ID: 6118102 [No Abstract] [Full Text] [Related]
50. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)]. Ishihara T; Watanabe K; Takenaka F Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789 [No Abstract] [Full Text] [Related]
52. [Effect of a new beta blockader (SD/1601) on positive levelling of the ST epicardial tracing during coronary occlusion in the narcotized dog]. Merlo L; Brusoni B; Minoia G; Marchetti G Boll Soc Ital Biol Sper; 1977 Mar; 53(6):440-4. PubMed ID: 20906 [No Abstract] [Full Text] [Related]